8-K filing — Xylem Inc. (XYL)
Filed: 2026-09-29 AccNo: 0001524472-26-000134 Size: 926 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Stocks · News reference
UBS Maintains Neutral on Xylem, Lowers Price Target to $112
UBS analyst Joshua Spector maintains Xylem (NYSE:XYL) with a Neutral and lowers the price target from $138 to $112.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Wolfe Research Assumes Xylem at Peer Perform
Wolfe Research analyst Nigel Coe assumes Xylem (NYSE:XYL) with a Peer Perform rating.
Trends & Strategies Shaping the $1.57 Billion Electro-Oxidation Market 2026-2035
The global electro-oxidation market is expected to grow at a CAGR of 6.13% from 2026 to 2035, driven by stricter wastewater regulations, water scarcity, and demand for sustainable treatment technologies. The market spans industrial and municipal wastewater treatment, with innovations in electrode materials and hybrid nanofiltration systems. Asia-Pacific leads in market share while North America shows the highest growth rate.